Clinical Manifestations of Insulin Resistance in Youth

Melinda E. Chen, Tamara S. Hannon

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The ongoing obesity epidemic places about a third of American youth at risk for developing obesity-related insulin resistance. This is manifested by reduced multiorgan effects of insulin, leading to elevated insulin concentrations and, in some cases, inappropriately elevated glucose and lipid concentrations. Many risk factors for insulin resistance—including genetics, epigenetics, obesity, diet, and lifestyle—are in common between adolescents and adults. However, adolescents have a unique risk factor in the physiologic insulin resistance of puberty, which along with obesity can pose a “double hit” to the beta-cell, causing increased burden for insulin secretion. The diagnosis of insulin resistance-related health conditions is more difficult in pediatric patients, due to physiological growth and change that makes the establishment of standards difficult. Such conditions include nonalcoholic fatty liver disease, polycystic ovary syndrome, metabolic syndrome, prediabetes, type 2 diabetes, and lipodystrophies, each of which would obligate additional screening or treatment. Research on treatment options generally addresses holistic changes in diet and lifestyle, with or without the addition of insulin sensitizers. Though these interventions require diligence and can be difficult to maintain, even small successes can create improvements to measured insulin resistance.

Original languageEnglish (US)
Title of host publicationContemporary Endocrinology
PublisherHumana Press Inc.
Pages3-17
Number of pages15
DOIs
StatePublished - Jan 1 2020

Publication series

NameContemporary Endocrinology
ISSN (Print)2523-3785
ISSN (Electronic)2523-3793

Fingerprint

Insulin Resistance
Insulin
Obesity
Diet
Lipodystrophy
Prediabetic State
Polycystic Ovary Syndrome
Puberty
Epigenomics
Type 2 Diabetes Mellitus
Life Style
Pediatrics
Lipids
Glucose
Health
Therapeutics
Growth
Research

Keywords

  • Insulin resistance
  • Insulin sensitivity
  • Lipodystrophy
  • Metabolic syndrome
  • NAFLD
  • NASH
  • Obesity
  • PCOS
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Chen, M. E., & Hannon, T. S. (2020). Clinical Manifestations of Insulin Resistance in Youth. In Contemporary Endocrinology (pp. 3-17). (Contemporary Endocrinology). Humana Press Inc.. https://doi.org/10.1007/978-3-030-25057-7_1

Clinical Manifestations of Insulin Resistance in Youth. / Chen, Melinda E.; Hannon, Tamara S.

Contemporary Endocrinology. Humana Press Inc., 2020. p. 3-17 (Contemporary Endocrinology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, ME & Hannon, TS 2020, Clinical Manifestations of Insulin Resistance in Youth. in Contemporary Endocrinology. Contemporary Endocrinology, Humana Press Inc., pp. 3-17. https://doi.org/10.1007/978-3-030-25057-7_1
Chen ME, Hannon TS. Clinical Manifestations of Insulin Resistance in Youth. In Contemporary Endocrinology. Humana Press Inc. 2020. p. 3-17. (Contemporary Endocrinology). https://doi.org/10.1007/978-3-030-25057-7_1
Chen, Melinda E. ; Hannon, Tamara S. / Clinical Manifestations of Insulin Resistance in Youth. Contemporary Endocrinology. Humana Press Inc., 2020. pp. 3-17 (Contemporary Endocrinology).
@inbook{7cbfe7438a0748899cf38e67c49366b1,
title = "Clinical Manifestations of Insulin Resistance in Youth",
abstract = "The ongoing obesity epidemic places about a third of American youth at risk for developing obesity-related insulin resistance. This is manifested by reduced multiorgan effects of insulin, leading to elevated insulin concentrations and, in some cases, inappropriately elevated glucose and lipid concentrations. Many risk factors for insulin resistance—including genetics, epigenetics, obesity, diet, and lifestyle—are in common between adolescents and adults. However, adolescents have a unique risk factor in the physiologic insulin resistance of puberty, which along with obesity can pose a “double hit” to the beta-cell, causing increased burden for insulin secretion. The diagnosis of insulin resistance-related health conditions is more difficult in pediatric patients, due to physiological growth and change that makes the establishment of standards difficult. Such conditions include nonalcoholic fatty liver disease, polycystic ovary syndrome, metabolic syndrome, prediabetes, type 2 diabetes, and lipodystrophies, each of which would obligate additional screening or treatment. Research on treatment options generally addresses holistic changes in diet and lifestyle, with or without the addition of insulin sensitizers. Though these interventions require diligence and can be difficult to maintain, even small successes can create improvements to measured insulin resistance.",
keywords = "Insulin resistance, Insulin sensitivity, Lipodystrophy, Metabolic syndrome, NAFLD, NASH, Obesity, PCOS, Type 2 diabetes",
author = "Chen, {Melinda E.} and Hannon, {Tamara S.}",
year = "2020",
month = "1",
day = "1",
doi = "10.1007/978-3-030-25057-7_1",
language = "English (US)",
series = "Contemporary Endocrinology",
publisher = "Humana Press Inc.",
pages = "3--17",
booktitle = "Contemporary Endocrinology",

}

TY - CHAP

T1 - Clinical Manifestations of Insulin Resistance in Youth

AU - Chen, Melinda E.

AU - Hannon, Tamara S.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - The ongoing obesity epidemic places about a third of American youth at risk for developing obesity-related insulin resistance. This is manifested by reduced multiorgan effects of insulin, leading to elevated insulin concentrations and, in some cases, inappropriately elevated glucose and lipid concentrations. Many risk factors for insulin resistance—including genetics, epigenetics, obesity, diet, and lifestyle—are in common between adolescents and adults. However, adolescents have a unique risk factor in the physiologic insulin resistance of puberty, which along with obesity can pose a “double hit” to the beta-cell, causing increased burden for insulin secretion. The diagnosis of insulin resistance-related health conditions is more difficult in pediatric patients, due to physiological growth and change that makes the establishment of standards difficult. Such conditions include nonalcoholic fatty liver disease, polycystic ovary syndrome, metabolic syndrome, prediabetes, type 2 diabetes, and lipodystrophies, each of which would obligate additional screening or treatment. Research on treatment options generally addresses holistic changes in diet and lifestyle, with or without the addition of insulin sensitizers. Though these interventions require diligence and can be difficult to maintain, even small successes can create improvements to measured insulin resistance.

AB - The ongoing obesity epidemic places about a third of American youth at risk for developing obesity-related insulin resistance. This is manifested by reduced multiorgan effects of insulin, leading to elevated insulin concentrations and, in some cases, inappropriately elevated glucose and lipid concentrations. Many risk factors for insulin resistance—including genetics, epigenetics, obesity, diet, and lifestyle—are in common between adolescents and adults. However, adolescents have a unique risk factor in the physiologic insulin resistance of puberty, which along with obesity can pose a “double hit” to the beta-cell, causing increased burden for insulin secretion. The diagnosis of insulin resistance-related health conditions is more difficult in pediatric patients, due to physiological growth and change that makes the establishment of standards difficult. Such conditions include nonalcoholic fatty liver disease, polycystic ovary syndrome, metabolic syndrome, prediabetes, type 2 diabetes, and lipodystrophies, each of which would obligate additional screening or treatment. Research on treatment options generally addresses holistic changes in diet and lifestyle, with or without the addition of insulin sensitizers. Though these interventions require diligence and can be difficult to maintain, even small successes can create improvements to measured insulin resistance.

KW - Insulin resistance

KW - Insulin sensitivity

KW - Lipodystrophy

KW - Metabolic syndrome

KW - NAFLD

KW - NASH

KW - Obesity

KW - PCOS

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85073522021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073522021&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-25057-7_1

DO - 10.1007/978-3-030-25057-7_1

M3 - Chapter

AN - SCOPUS:85073522021

T3 - Contemporary Endocrinology

SP - 3

EP - 17

BT - Contemporary Endocrinology

PB - Humana Press Inc.

ER -